Effect of cryopreservation on measurement of cytomegalovirus-specific cellular immune responses in HIV-infected patients

Journal of Acquired Immune Deficiency Syndromes

Volumn 25, Issue 2, 2000, Pages 109-114

  Weinberg, Adriana ^a   Wohl, David A ^b   Brown, Darby G ^a   Pott, Gregory B ^a   Zhang, Li ^a   Ray, M Graham ^a   Van Der Horst, Charles ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Cell mediated immunity; Cryopreservation; Cytomegalovirus; HIV infection

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2;

ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYOPRESERVATION; CYTOKINE RELEASE; CYTOMEGALOVIRUS; CYTOMETRY; FEASIBILITY STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION; VIRUS LOAD;

EID: 0034298647     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200010010-00004     Document Type: Article

References (13)

1. Clinical evaluation of the safety and efficacy of ritonavir (ABT-538), an inhibitor of HIV-1 protease
2. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
3. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy
4. Relapse of CMV retinitis in an AIDS patient with high CD4 counts
5. CMV retinitis in an HIV-infected patient on prolonged and effective highly active antiretroviral therapy (HAART)
6. Alterations in the immune response of human immunodeficiency virus-infected subjects treated with an HIV-specific protease inhibitor, ritonavir
7. + T cell homeostasis and function in advanced HIV disease
8. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine and ritonavir: Results of AIDS Clinical Trials Group Protocol 315
9. + T-cell reactivity to microbial antigens but not to HIV-1 antigens
10. + T cell
11. Effect of shipment, storage, anticoagulant and cell separation on lymphoproliferative responses in HIV-infected patients
12. Limiting dilution analysis
13. + T cell frequencies by flow cytometry